Clinical Trial Update: Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing PET tracers [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide for detecting prostate cancer before prostatectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ImaginAb tracer [89Zr]-Df-IAb2M (Df-IAb2M labeled with Zirconium-89)
• [111In]-Capromab Pendetide (Capromab Pendetide)

Snippet

Sponsor: ImaginAb, Inc. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED